UNSPSC 51271805: Rolicyclidine

This classification denotes a sedative and hypnotic with the molecular formula C16H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 183O9O9JE3, chemically known as pyrrolidine, 1-(1-phenylcyclohexyl)- but generally known as rolicyclidine, which bears US NIH Compound Identifier 62436. European Medicines Agency schedules Rolicyclidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10365MIG.

UNSPSC 51271805 Rolicyclidine is a Commodity code that covers pharmaceutical active ingredients and chemical compounds used in drug manufacturing and preparation. State and local governments procure under this code primarily through cooperative purchasing agreements that aggregate demand across multiple jurisdictions for generic pharmaceuticals and over-the-counter products. The work involves securing supply agreements with manufacturers who can deliver products meeting FDA compliance, cGMP certification, and Drug Supply Chain Security Act requirements, with products distributed through authorized wholesale channels to state and local healthcare facilities, correctional institutions, and other government medical operations. Issuing bodies are typically state procurement offices administering multistate cooperative purchasing vehicles, which consolidate purchasing power across participating states and local government entities to negotiate volume pricing and establish standing supplier contracts.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline. The solicitation requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded vendors effective July 1, 2026 and contract terms of two years for new responders. Evaluation weighting emphasizes price competitiveness (75 percent) with secondary weight on fixed pricing (10 percent), EDI capability (5 percent), administrative fee compliance (5 percent), and data format compliance (5 percent). Vendors must maintain minimum commercial general liability insurance of $5,000,000 per occurrence and professional liability of $2,000,000, demonstrate contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, and accept a 3 percent administrative fee on contract purchases.